Introduction: Ultrasound sonography (US)-guided navigation systems are widely used in various organs, including the breast and liver, to locate precisely lesions that are difficult to palpate or isolate after being identified by other imaging techniques. A recent new method, "volume navigation" (Vnav), delivers real-time image fusion of US with other modalities such as MRI, CT, and PET/CT to facilitate identification and excision of suspected pathology.
Presentation Of Case: The present report describes a novel navigation technique using Vnav-PET/CT, which delivers image fusion of US with PET/CT. To identify the axillary targets using Vnav-PET/CT, we set at least two landmarks then injected 0.2ml viscous blue dye in and around the capsule, which resulted in precise resection. Case 1: A 53-year-old woman with 2 PET/CT-positive lymph nodes in the right axilla underwent easy identification of the targets using the navigation technique followed by lymph node dissection. Among 32 lymph nodes dissected, only the two lymph nodes stained by blue dye were shown histologically to be malignant. Case 2: A 68-year-old woman had a PET/CT-positive lymph node in the left axilla. Vnav-PET/CT easily identified the target, which was successfully dissected under local anaesthesia.
Discussion: This navigation and marking using Vnav-PET/CT helped us easily approach the target, resulted in less surgical time, and avoided unsatisfactory axillary complications. These advances of the navigation system enable us to perform precise minimally invasive surgery.
Conclusion: This is the first report of navigation surgery using Vnav-PET/CT, which may assist minimally invasive procedures, especially in the axilla.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710893 | PMC |
| http://dx.doi.org/10.1016/j.ijscr.2013.05.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Initial clinical experience with [Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial.
Front Oncol
January 2025
Department of Clinical Development, POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, Indianapolis, IN, United States.
Introduction: SPLASH (NCT04647526) is a multicenter phase III trial evaluating the efficacy and safety of [Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer (mCRPC). This study leveraged a lead-in phase to assess tissue dosimetry and evaluate preliminary safety and efficacy, prior to expansion into a randomized phase. Here we report those results.
View Article and Find Full Text PDFUsing multimodal ultrasound technology to improve the success rate of liver tumor puncture for lesions with poor visibility on conventional ultrasound imaging.
Quant Imaging Med Surg
January 2025
Department of Ultrasonography, Nanjing Drum Tower Hospital, Drum Tower Clinical Medical College, Nanjing Medical University, Nanjing, China.
Background: The ability of conventional ultrasound (US)-guided liver biopsy to visualize certain liver lesions, particularly those affected by conditions like hepatitis or cirrhosis, which can obscure lesion boundaries and lead to inaccurate biopsy targeting, is limited. This study aimed to evaluate the potential of multimodal US techniques to improve the visibility of liver lesions that are indistinct under conventional US, and to enhance the success rate of percutaneous biopsies.
Methods: In total, 144 patients with liver masses and lesions that were not clearly visible on conventional US from October 2018 to January 2024 were enrolled in this retrospective analysis.
Multi-stream and multi-scale fusion rib fracture segmentation network based on UXNet.
Quant Imaging Med Surg
January 2025
School of Computer Science and Technology, Changchun University of Science and Technology, Changchun, China.
Background: Accurate segmentation of rib fractures represents a pivotal procedure within surgical interventions. This meticulous process not only mitigates the likelihood of postoperative complications but also facilitates expedited patient recuperation. However, rib fractures in computed tomography (CT) images exhibit an uneven morphology and are not fixed in position, posing difficulties in segmenting fractures.
View Article and Find Full Text PDFMacNet: a mobile attention classification network combining convolutional neural network and transformer for the differentiation of cervical cancer.
Quant Imaging Med Surg
January 2025
Research Center for Medical AI, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Background: Cervical cancer remains a critical global health issue, responsible for over 600,000 new cases and 300,000 deaths annually. Pathological imaging of cervical cancer is a crucial diagnostic tool. However, distinguishing specific areas of cellular differentiation remains challenging because of the lack of clear boundaries between cells at various stages of differentiation.
View Article and Find Full Text PDFSeg-SkiNet: adaptive deformable fusion convolutional network for skin lesion segmentation.
Quant Imaging Med Surg
January 2025
School of Computer and Control Engineering, Yantai University, Yantai, China.
Background: Skin lesion segmentation plays a significant role in skin cancer diagnosis. However, due to the complex shapes, varying sizes, and different color depths, precise segmentation of skin lesions is a challenging task. Therefore, the aim of this study was to design a customized deep learning (DL) model for the precise segmentation of skin lesions, particularly for complex shapes and small target lesions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!